Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just make it private
End there facade and legal thievery
All of it legal as a pretty yellow ribbon
The illusion of a company
The illusion of an asset
and all the while ..
There is nothing there..
A sociopath couldn’t do it any better..
Pay a few people to pump before the next news cycle..
Voila.. Pennies from Hell
Let me guess
The Caesar share owner
Is the exact same guy
That controls the Foundation?
Wow..
They just stole the only asset that matters
They don’t change Patent Owners
Well a Foundation now owns the Patent?
Hun..
so propane owns ….
Wait for it..
I have researched all the SEC FILINGS. This company and the technology is going no where.
It has become a vehicle for the CEO and his wife to extract large amounts of money and fund their lifestyle. It has been the same vague promises, issue of convertible notes and reverse stock splits each year. If you choose to invest in this company without doing your research you are effectively handing your money over to them with little to no prospect of getting it back.
Outstanding Share Count updated with 1-9-2024 as the date.... over 40% more shares issued (over 12 million shares issued in a month).
Outstanding: 39.3 million
Restricted: 727k
Unrestricted: 38.5 million
PPCB ?!?!?!?!
Go. Ppcb. Diamond hands… Weak hands. always fold.
Go. Ppcb. I now have 60,000 shares I’m gonna get another hundred thousand shares in the next month let’s go this is the very bottom this thing could easily hit a dollar and not too distant future.
So sick of holding this pile...they either don't have anything or they are clueless how to move forward with the product they have. Stay away...next RS will probably be a 1:10,000. Last one was a huge gut punch. I actually think these folks have learned how to live off of OPM and really don't care whether anything comes of this or not...prove me wrong Nathanielz!
Will 2024 be the year, unlike 2012,2013,2014,2015,2016,2017,2018,2019,1020,2021,2022 or 2023? I have some doubts, while CEO will likely pocket another 450k this year to the expense of the shareholders
yes and its trading real nice the last month.... I will be trying to buy more here soon!
Lets Go PPCB !!!!!!!!! Human Trials Soon !!!!!!!!!
GLTY
Looks like it survived the stock promotion CE. Not many do.
tomorrow should be the day since it happened the next day after the 12-13 Press Release.
Isnt the 15 days for the stock promotion label up today?
I love the way this has been trading the past couple of weeks....
very low Outstanding Share Count ~ 27 million and it doesn't look like its increased much since 12-09.
Lets Go PPCB !!!!!!!!!!
Hope you make some $$ here. Looks scammy af but most of them are these days.
its been trading nice the past couple of weeks and it looks like dilution has slowed down.... ive always gotten beat up with this stock so I only bought a little, lol. if it goes up like it has the past couple of weeks ill be happy.
lol, this one is a joke.
ok, im in again for a little.... lets hope this time I can finally make some money off of PPCB!!!!!!!!!
Lets Go PPCB !!!!!!!! Human Trials Soon !!!!!!!!!!!!!!
hinting at massive dilution and yet another round of toxic financing...
funny; PPCB has a "Stock Promotion" label and they release another PR.
around 5.5 million shares added to the Outstanding Share Count from 11-09 to 12-09, dilution did slow down from the previous update..... im contemplating on getting back in but would like to see what happens with the "Stock Promotion" label on otcmarkets.com.
Good Luck Everyone!
Be careful here MSG, a CE usually comes after the stock promotion label is placed.
first time ive ever seen "stock promotion" label for PPCB on otcmarkets.com !!!! https://www.otcmarkets.com/stock/PPCB/overview
it seems like someone was pumping the crap out of this on social media.
almost half the Outstanding Share Count (from last update on 11-09) already traded today, on silly news also!
Good luck to you as well! I agree - if they have a breakthrough treatment it would be massive.
Look at that, it's already down 8 percent now haha....crazy volatility.
ive been in and out of this stock for years. It has its "spurts" that never last and I seem to get out right before one!!!!
This Company has potential for a huge breakthrough and I want to be in when it announces concrete First in Human trials date. Their FIH trials is always "projected" to commence in the second quarter (for the last 6 years at least).
I expect news to come out every two weeks now since that is their MO. I will get back in before the end of this year (hopefully).
Good Luck To You!!!!
I got in before the RS LOL...long ago. I've thought about averaging down but this thing could just go belly up. Don't feel bad!
You're likely to get a chance to get in lower than when you sold. This has really spiraled downward.
my timing is always off with this company.... I sold last week for a loss!!!! I was in @ .008!!
Interesting - I was wondering the reason for this volume.
Last interview is the same rehash of the usual BS : no updated timeline ("next year", great) and pathetic reference to a patient who died in ... 2008. Nathanielz definitelyneeds to be coached on communication to start with, management of a company should be next on his list, because he might be dead before PRP ever hits the radar screen at the pace he has been running in the past 10 years
He must have reversed and issued a few billion more shares..
Donate to the sham of a public company if you want.. but never kid yourself
It’s a donation
over 6 million shares added since last Share Structure update.....
22.2 million Outstanding Shares
PPCB is back to being PPCB !!!!!!!!!!!
yes the real news will be the human trials and if were not in before that gets announced we will be playing catch up...... I would rather lose a few hundred dollars here and there gambling, then miss out on the announcement of human trials. I believe it will be well worth it.
In the meantime, were screwed!
GLTY
This is no news, a repeat of the same story from 5 years ago (remember the pictures of the rats back in 2017?). Real news will be the beginning of the FIH trials, delayed quarter after quarter after quarter. Meanwhile CEO os grasping his 450 k a year for delivering zero results, pathetic
news finally and ZERO volume...... hey pumpers where are you at now????????????
https://www.otcmarkets.com/stock/PPCB/news/story?e&id=2682433
congrats, you did it again, back to sub penny land. Natanielz has to go or "work"(?) for free from now on, or get drowned in his billabong
we are in the same boat. First buy in 2015 at a whopping 250000000 dollars a share after all these reverse splits...
we get "revised" timelines every year and they usually say "in the second half of next year we anticipate." Im not sure if you've followed this company as long as I have, but ive been watching this stock for about 8 years (at least).
What we need is a revised PRP timelines compated to last presentation. This was stating :
- CTA approval mid-August
- Study preparation end of October, same for preparation of logistics and trial site initiation visits
- FPFV (first patient/first visit) : late November.
So here we are end of October : what, if anyything, has been achieved at this stage ,where do we stand on financing these FIH trials, or are we closing shop indifinitely? Basic follow-up on former promises is all we need, nobody forced them to publish these timelines earlier. Looks like things are working differently down under
Yep, by Friday COB at this rate.
Yeah, be back under a penny by the end of the month.
Followers
|
407
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
48342
|
Created
|
05/18/14
|
Type
|
Free
|
Moderators |
This section maintained by INV4
Offering New Hope to Cancer Patients and Their Caregivers
About Propanc Biopharma, Inc. The Company’s novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body’s primary defense against cancer. A Long-Term Therapy Based on a Pancreatic Proenzyme Formulation Developing Long-Term Therapy for the Treatment of Solid Tumors Technology Based on Pancreatic Proenzyme Therapy Treatments that Inhibit Tumor Growth and Metastasis Our Lead Product: PRP Technology Based on Pancreatic Enzyme Therapy More than one hundred years ago, Professor John Beard first proposed that the pancreatic enzymes represent the body’s primary defense against cancer and would be useful as a cancer treatment. Since then, several scientists have endorsed Beard´s hypothesis with encouraging data from patient treatment. |
Click here for the video (with sound)
====================== PPCB SECURITY DETAILS ======================
Share Structure
Market Cap | 1,652,679 | 02/27/2023
Authorized Shares | 10,000,000,000 | 02/13/2023
Outstanding Shares | 1,836,310,391 | 02/13/2023
Restricted | 194,354,827 | 02/13/2023
Unrestricted | 1,641,955,564 | 02/13/2023
Held at DTC | 1,641,916,456 | 02/13/2023
Board of Directors James Nathanielsz has served as a director and Chief Executive Officer of our company since October 2007. From July 2006 until October 2007, Mr. Nathanielsz served as the New Products Manager of Biota Holdings Limited, an anti-infective drug development company in Australia. Mr. Nathanielsz was selected as a director because he is the Co-Founder of Propanc and for his experience in R&D and manufacturing and distribution. Mr. Nathanielsz holds a B.App.Sci in Biochemistry/Applied Chemistry and an M.E.I. from Swinburne University of Technology in Melbourne, Australia. ============== Dr. Julian Kenyon founded our company and was appointed as a director on February 12, 2008. Since 2000, Dr. Kenyon has served as an integrated medical physician and Medical Director of the Dove Clinic for Integrated Medicine in Winchester and London. He was the Founder-Chairman of the British Medical Acupuncture Society in 1980 and Co-Founder of the Centre for the Study of Complementary Medicine in Southampton and London. Dr. Kenyon was selected as a director because he is the Co-Founder of the Australian subsidiary and the business is based on his initial work at the Dove Clinic. Dr. Kenyon holds an M.B.Ch.B. and M.D. from the University of Liverpool Since 1972, he was appointed a Primary Fellow of the Royal College of Surgeons, Edinburgh. ============== Mr Zelinger is a Certified Practicing Accountant with 45 years of experience in tax, auditing, finance, investment and management consulting. Mr Zelinger also has significant expertise in property management and import/export businesses. Mr Zelinger commenced his career as an accountant at L.M. Stanton & Partners - Chartered Accountants, subsequently joining Caston Pty Ltd in 1980, a steel manufacturer as Chief Financial Officer, and Company Director, until 1983. Since the mid-1980’s until current date, Mr Zelinger serves as Director in several private investment companies in a range of businesses including property portfolio manager of commercial real estate, import/export businesses and a range of commercial and financial investment companies. Since 1980, Mr Zelinger also operates as a sole practitioner in accountancy and tax consulting. In 1973, Mr Zelinger graduated in Accounting and admitted as a Fellow of RMIT University in Business. He has been a Certified Practicing Accountant since 1984. Mr. Zelinger is a shareholder of Propanc Biopharma Inc. since 2010. ======================================================================== Company Info Industry Classifications |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |